Canada warns U.S. against drug import plans, citing shortage concerns

18 July 2019 - Canada opposes any U.S. plans to buy Canadian prescription drugs that might threaten the country’s drug supply ...

Read more →

Patient registries may prove valuable in regulatory decisions, EMA study finds

18 July 2019 - Although patient registries can be heterogenous in their quality and design, a new study in Drug ...

Read more →

Was it really a smart move for the FDA to approve a ‘smart pill’ for treating schizophrenia?

18 July 2019 - In late 2017, the FDA approved the first so-called smart pill, ushering in a new era ...

Read more →

Meningococcal B vaccine must be urgently added to the National Immunisation Program

19 July 2019 - It is particularly cruel that the people with the most life to live are the prime ...

Read more →

PBAC Public Summary Documents (first time rejections and deferrals) - March 2019 meeting

19 July 2019 - The Public Summary Documents (first time rejections and deferrals) from the March 2019 PBAC meeting are now ...

Read more →

Evaluation of ethical analyses in seven reports from the European Network for Health Technology Assessment

16 July 2019 - Ethics has been considered among the core domains of health technology assessment, but there are still ...

Read more →

Personalised treatments may be threatened by drug cost-containment proposals

18 July 2019 - President Trump has said he plans to issue an executive order to lower what the United ...

Read more →

Toddler died of only meningococcal strain not on vaccine program

18 July 2019 - A toddler has died after contracting meningococcal B, the only strain of the potentially deadly disease with ...

Read more →

Health insurance rebate still a pain in the budget

18 July 2019 - The private health insurance sector wants increased rebates to stop the recent decline in membership.  ...

Read more →

Horizon Therapeutics announces U.S. FDA acceptance of its new drug application to make Procysbi (cysteamine bitartrate) available as oral granules in packets

18 July 2019 - Horizon Therapeutics announced today that the U.S.FDA has accepted Horizon’s new drug application for Procysbi (cysteamine bitartrate) ...

Read more →

Two cancer immunotherapy makers face different situations in reimbursement talks

18 July 2019 - MSD returns to renegotiation table; BMS suffers from partner’s silence. ...

Read more →

Private health insurance worthy of support

17 July 2019 - While there are many who have strong ideological objections to the use of taxpayers' money to ...

Read more →

House votes to repeal Obamacare tax once seen as key to health law

18 July 2019 - In the heat of the legislative fight over the Affordable Care Act, Obama administration officials argued ...

Read more →

LifeMax receives rare paediatric disease designation for LM-030 for the treatment of Netherton syndrome

18 July 2019 - LifeMax Laboratories today announced that the FDA granted rare paediatric disease designation to LM-030, an investigational therapy ...

Read more →

Part D beneficiaries may pay more for some generics, biosimilars than brand name drugs

16 July 2019 - Medicare Part D enrolees may actually pay more for some generic drugs than they would for their ...

Read more →